Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             145 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advantages and disadvantages of combination treatment with antipsychotics Goodwin, Guy
 2009
 19 Supplement 2 p. 520-532
13 p.
 artikel
2 Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients Shiloh, Roni
 2009
 19 Supplement 2 p. 654-658
5 p.
 artikel
3 Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study Dell'Agnello, Grazia
 2009
 19 Supplement 2 p. 822-834
13 p.
 artikel
4 BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans Appel, Lieuwe
 2009
 19 Supplement 2 p. 841-850
10 p.
 artikel
5 Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: Compound-specific and area-specific distribution within the brain Barna, I.
 2009
 19 Supplement 2 p. 533-541
9 p.
 artikel
6 Call for Breaking News 2009
 19 Supplement 2 p. II-
1 p.
 artikel
7 C.05.02 Disruption of the circadian timing systems in depression Mendlewicz, J.
 2009
 19 Supplement 2 p. S708-S709
2 p.
 artikel
8 C.11.02 Emerging preclinical data and models – what's new? Neill, J.
 2009
 19 Supplement 2 p. S714-
1 p.
 artikel
9 C.16.03 Long-term management of bipolar disorder Grunze, H.
 2009
 19 Supplement 2 p. S720-
1 p.
 artikel
10 Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate Trezza, Viviana
 2009
 19 Supplement 2 p. 659-669
11 p.
 artikel
11 Contents 2009
 19 Supplement 2 p. OBC-
1 p.
 artikel
12 Contents 2009
 19 Supplement 2 p. OBC-
1 p.
 artikel
13 C.15.03 Symptom relief achieved at every stage of depression treatment Kennedy, S.
 2009
 19 Supplement 2 p. S719-
1 p.
 artikel
14 C.04.02 Understanding the full potential of treatments informed by evidence Cookson, J.
 2009
 19 Supplement 2 p. S707-S708
2 p.
 artikel
15 Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells Park, Sung Woo
 2009
 19 Supplement 2 p. 356-362
7 p.
 artikel
16 Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose Peles, Einat
 2009
 19 Supplement 2 p. 581-588
8 p.
 artikel
17 ECNP Calendar of Events 2009
 19 Supplement 2 p. I-
1 p.
 artikel
18 Editorial Board 2009
 19 Supplement 2 p. IFC-
1 p.
 artikel
19 E.02.03 Efficacy markers in depression Harmer, C.
 2009
 19 Supplement 2 p. S219-S220
2 p.
 artikel
20 Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects Kato, Masaki
 2009
 19 Supplement 2 p. 718-725
8 p.
 artikel
21 Effects of risperidone on glutamate receptor subtypes in developing rat brain Choi, Yong Kee
 2009
 19 Supplement 2 p. 77-84
8 p.
 artikel
22 Electrophysiological characterization of the effects of asenapine at 5-HT1A, 5-HT2A, α2-adrenergic and D2 receptors in the rat brain Ghanbari, Ramez
 2009
 19 Supplement 2 p. 177-187
11 p.
 artikel
23 Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits Davis, Jennifer A.
 2009
 19 Supplement 2 p. 551-561
11 p.
 artikel
24 Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study Pae, Chi-Un
 2009
 19 Supplement 2 p. 562-570
9 p.
 artikel
25 Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice Mechanic, Jordan A.
 2009
 19 Supplement 2 p. 466-475
10 p.
 artikel
26 KL.01 Bipolar disorders Goodwin, G.M.
 2009
 19 Supplement 2 p. S103-
1 p.
 artikel
27 Mirtazapine and paroxetine in major depression: A comparison of monotherapy versus their combination from treatment initiation Blier, Pierre
 2009
 19 Supplement 2 p. 457-465
9 p.
 artikel
28 Modulation of sickness behavior by sleep: The role of neurochemical and neuroinflammatory pathways in mice Zager, Adriano
 2009
 19 Supplement 2 p. 589-602
14 p.
 artikel
29 P.2.a.028 Acute and chronic effects of naturalistically smoked cannabis on depression and anxiety Freeman, T.P.
 2009
 19 Supplement 2 p. S376-
1 p.
 artikel
30 P.6.a.008 A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol dependent subjects Watson, B.J.
 2009
 19 Supplement 2 p. S640-
1 p.
 artikel
31 P.1.a.011 Association of the serotonin transporter intron 2 VNTR polymorphism with treatment response to mirtazapine Lee, H.Y.
 2009
 19 Supplement 2 p. S231-
1 p.
 artikel
32 P.1.a.024 Association study of rs2289656, polymorphism of the NTRK2 gene with bipolar disorder and it subtypes Rajewska-Rager, A.
 2009
 19 Supplement 2 p. S239-
1 p.
 artikel
33 P.1.a.022 Cytosolic phospholipase A2 Banl and cyclooxygenase-2 G-765C polymorphisms in Alzheimer's disease Feher, A.
 2009
 19 Supplement 2 p. S238-
1 p.
 artikel
34 P.2.a.045 Depressed patients show altered neural responses to an emotional Stroop task after response to citalopram treatment Pegg, E.
 2009
 19 Supplement 2 p. S386-
1 p.
 artikel
35 P.3.03 A double-blind, placebo-controlled, parallel group study of the effect of Org 25935 on cognitive performance Christmas, D.
 2009
 19 Supplement 2 p. S64-S65
2 p.
 artikel
36 P.5.a.001 Dropouts due to other reasons than adverse events during clinical trials in Alzheimer's disease Kani, C.
 2009
 19 Supplement 2 p. S619-S620
2 p.
 artikel
37 P.4.a.014 Efficacy and safety of repeated TMS in the treatment of refractory obsessive-compulsive disorder Chae, J.
 2009
 19 Supplement 2 p. S593-
1 p.
 artikel
38 P.6.a.005 Factors influencing drinking behaviour during pregnancy in Korean women Kim, S.G.
 2009
 19 Supplement 2 p. S638-
1 p.
 artikel
39 P.1.a.021 Genetic association of MTHFR gene with schizophrenia and bipolar disorder Kim, S.
 2009
 19 Supplement 2 p. S237-
1 p.
 artikel
40 P.7.a.007 Is there a link between a history of childhood trauma and cognitive impairment in first-episode psychosis? Aas, M.
 2009
 19 Supplement 2 p. S682-
1 p.
 artikel
41 P.2.a.03l A cross-cultural, comparative study of the prevalence and symptom patterns of depression among college students Parikh, R.
 2009
 19 Supplement 2 p. S378-
1 p.
 artikel
42 P.3.a.03l Comorbid depression and treatment attitude among out-patients with schizophrenia or schizoaffective disorder Frikha, A.
 2009
 19 Supplement 2 p. S498-
1 p.
 artikel
43 P.4.a.01l Quetiapine monotherapy in chronic posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial Hamner, M.
 2009
 19 Supplement 2 p. S591-S592
2 p.
 artikel
44 P.3.a.017 Paliperidone extended-release for the treatment of bipolar mania Leotsakou, C.
 2009
 19 Supplement 2 p. S489-S490
2 p.
 artikel
45 P.8.a.012 Psychiatric comorbidity in females with vaginismus Yildirim, E.A.
 2009
 19 Supplement 2 p. S700-S701
2 p.
 artikel
46 P.3.a.014 Psychotic disorder with underlying Graves disease: a case report Zaharie, A.M.
 2009
 19 Supplement 2 p. S488-
1 p.
 artikel
47 P.3.01 Aripiprazole reduces risperidone-induced hyperprolactinemia: two case reports Capasso, A.
 2009
 19 Supplement 2 p. S151-
1 p.
 artikel
48 P.1.a.007 The role of insulin receptor substrate-1 Gly972Arg polymorphism in the pathogenesis of Alzheimer's disease Juhasz, A.
 2009
 19 Supplement 2 p. S228-S229
2 p.
 artikel
49 P.2.a.014 The triallelic 5-HTTLPR polymorphism may be associated with major depression in male Han Chinese population Huang, S.Y.
 2009
 19 Supplement 2 p. S368-S369
2 p.
 artikel
50 P.6.b.009 Alcohol dehydrogenase gene polymorphism in Korean alcohol addicted patients Shin, C.
 2009
 19 Supplement 2 p. S647-S648
2 p.
 artikel
51 P.4.b.009 Association between obsessive-compulsive disorder and glutamate n-methyl-d-aspartate2b subunit receptor gene Kim, C.
 2009
 19 Supplement 2 p. S601-S602
2 p.
 artikel
52 P.1.b.007 Developmental expression and activity of carboxylesterase 1 and carboxylesterase 2 in mouse and human Zhu, H.J.
 2009
 19 Supplement 2 p. S244-S245
2 p.
 artikel
53 P.2.b.017 Differences in 5-HT1A neurotransmission between rats displaying a persistent high or low exploratory phenotype Kõiv, K.
 2009
 19 Supplement 2 p. S400-S401
2 p.
 artikel
54 P.2.b.003 Endothelial dysfunction in a rodent model of depression may underlie atherosclerosis formation Isingrini, E.
 2009
 19 Supplement 2 p. S392-
1 p.
 artikel
55 P.2.b.021 First characterisation of tryptophan hydroxylase-2 (Tph2) knockout mice Gutknecht, L.
 2009
 19 Supplement 2 p. S403-
1 p.
 artikel
56 P.2.b.020 5-HT2C receptor activation inhibits stress-induced increase in 5-HT transmission: relevance of receptor desensitization to the anxiolytic effect chronic antidepressant drugs and mutation in mice Mongeau, R.
 2009
 19 Supplement 2 p. S402-S403
2 p.
 artikel
57 P.1.b.012 Locus coeruleus and dorsal raphe nucleus neuron activity in control, parkinsonian and dyskinetic animals Miguelez, C.
 2009
 19 Supplement 2 p. S247-
1 p.
 artikel
58 P.6.b.002 Matrix metalloproteinase 2 (MMP2) concentration among alcohol dependent inpatient women Augustynska, B.
 2009
 19 Supplement 2 p. S643-S644
2 p.
 artikel
59 P.1.c.035 Celecoxib, a cyclooxygenase-2 inhibitor enhances pentylenetetrazole induced seizure threshold in mice Mesdaghinia, A.
 2009
 19 Supplement 2 p. S271-S272
2 p.
 artikel
60 P.3.c.037 Cognitive functions and PANSS scores in a cohort of patients with schizophrenia treated with olanzapine Borkowska, A.
 2009
 19 Supplement 2 p. S531-S532
2 p.
 artikel
61 P.2.c.027 Daily treatment of patients with major depressive disorder: an exploratory study evaluating milnacipran and venlafaxine Gourion, D.
 2009
 19 Supplement 2 p. S419-
1 p.
 artikel
62 P.3.c.023 Delirium psychoses caused by antiparkinsonian drugs Sastre, J. Santiago
 2009
 19 Supplement 2 p. S523-S524
2 p.
 artikel
63 P.1.c.025 Differential effects of aripiprazole, amisulpride and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells Seo, M.K.
 2009
 19 Supplement 2 p. S266-
1 p.
 artikel
64 P.1.c.008 D-serine adjuvant treatment alleviates motor and behavioural symptoms in idiopathic Parkinson's disease Heresco-Levy, U.
 2009
 19 Supplement 2 p. S255-S256
2 p.
 artikel
65 P.3.c.054 Effect of diagnosis and treatment on cardio-metabolic risk in community psychiatric patients Mackin, P.
 2009
 19 Supplement 2 p. S541-
1 p.
 artikel
66 P.7.C.002 Effects of aripiprazole on glucose, lipids and weight in adolescent patients: a pooled analysis of 2 clinical trials Loze, J.Y.
 2009
 19 Supplement 2 p. S689-S690
2 p.
 artikel
67 P.4.c.010 Effects of diazepam on the processing of aversive faces: a fMRI study Del-Ben, C.M.
 2009
 19 Supplement 2 p. S609-S610
2 p.
 artikel
68 P6.c.012 Efficacy of melatonin in methadone maintained patients with insomnia: results from an open comparison study Stoychev, K.R.
 2009
 19 Supplement 2 p. S656-S657
2 p.
 artikel
69 P.3.c.068 Efficacy outcomes of risperidone long acting injection in patients previously on oral atypicals versus conventional depots Lam, A.
 2009
 19 Supplement 2 p. S549-S550
2 p.
 artikel
70 P.1.05 Chronic stress alters cocaine-induced modulation of BDNF expression and signaling in rat brain Caffino, L.
 2009
 19 Supplement 2 p. S6-S7
2 p.
 artikel
71 P.3.c.006 Life satisfaction, psychopathology and functional level in chronic schizophrenia undergoing antipsychotic treatment Jung, H.
 2009
 19 Supplement 2 p. S514-
1 p.
 artikel
72 P.3.c.051 Metabolic screening in serious mental illness outpatients in Function Assertive Community Treatment (FACT) in the Netherlands Cohen, D.
 2009
 19 Supplement 2 p. S539-S540
2 p.
 artikel
73 P.2.c.045 Outcome of escitalopram treatment based on baseline severity of depression Stamouli, S.
 2009
 19 Supplement 2 p. S429-
1 p.
 artikel
74 P.3.c.020 Paliperidone action on prolactin level in the real clinical practice: results Parise, V. Fricchione
 2009
 19 Supplement 2 p. S522-
1 p.
 artikel
75 P.1.c.049 Relation of proepileptic activity of indomethacin with adrenal gland hormones Suleyman, H.
 2009
 19 Supplement 2 p. S279-S280
2 p.
 artikel
76 P.2.c.030 Short-term antidepressant effectiveness and safety in bipolar non-rapid cycling depression: a naturalistic study Tundo, A.
 2009
 19 Supplement 2 p. S421-
1 p.
 artikel
77 P.7.c.003 Somnolence and sedation in adolescents with schizophrenia treated with aripiprazole (acute and long term follow-up) Loze, J.Y.
 2009
 19 Supplement 2 p. S690-S691
2 p.
 artikel
78 P.1.c.011 The changes in cortical BDNF level upon chronic administration of venlafaxine, olanzapine and nicotine Nowakowska, E.
 2009
 19 Supplement 2 p. S257-S258
2 p.
 artikel
79 P.1.c.039 The effects of valproic acid on the pancreas of rats Chung, J.H.
 2009
 19 Supplement 2 p. S274-
1 p.
 artikel
80 P.2.c.013 Two generic antidepressant medications and their bio-equivalence or bio-inequivalence Chenu, F.
 2009
 19 Supplement 2 p. S411-
1 p.
 artikel
81 P.2.c.032 Young patients with type 2 diabetes mellitus are frequently depressed Berge, L.
 2009
 19 Supplement 2 p. S422-
1 p.
 artikel
82 P6.d.002 Central administration of minocycline and riluzole prevents morphine-induced tolerance in rats Charkhpour, M.
 2009
 19 Supplement 2 p. S658-
1 p.
 artikel
83 P.3.d.020 Characterization of [3H]asenapine binding in sections of rat brain Shahid, M.
 2009
 19 Supplement 2 p. S565-S566
2 p.
 artikel
84 P.5.d.003 Decreased striatal dopamine turnover following administration of 7-nitroindazole to rats with L-DOPA-induced dyskinesia Del Bel, E.A.
 2009
 19 Supplement 2 p. S630-S631
2 p.
 artikel
85 P.1.d.004 Effects of green tea extract on behaviour in chronic lead intoxicated rats Rebai, O.
 2009
 19 Supplement 2 p. S289-
1 p.
 artikel
86 P.1.08 Differential immune response to maternal separation stress in male and female prenatally-stressed juvenile rats Desbonnet, L.
 2009
 19 Supplement 2 p. S9-
1 p.
 artikel
87 P.4.d.003 Increase in nociception and articular diameter after the dorsolateral periaqueductal gray chemical stimulation in rats Bertoglio, L.J.
 2009
 19 Supplement 2 p. S611-S612
2 p.
 artikel
88 P6.d.016 Long-lasting effects of transient food deprivation on an animal model of addiction de Almeida, E.
 2009
 19 Supplement 2 p. S666-S667
2 p.
 artikel
89 P.2.d.03l Trazodone increases extracellular serotonin levels in the frontal cortex of rats Garrone, B.
 2009
 19 Supplement 2 p. S447-
1 p.
 artikel
90 P.3.d.010 Pharmachological treatment in first psycotic episodes: glutamate and BDNF levels De Azua Garcia, S. Ruiz
 2009
 19 Supplement 2 p. S559-S560
2 p.
 artikel
91 P.2.d.017 Pharmacological profile of Lu AA21004, a novel multi-target drug for the treatment of mood disorders Mørk, A.
 2009
 19 Supplement 2 p. S439-
1 p.
 artikel
92 P.1.d.021 Preliminary experimental data regarding the effect on spontaneous activity of systemically administered cobalt Tamba, B.I.
 2009
 19 Supplement 2 p. S299-
1 p.
 artikel
93 P.3.d.007 The pattern of use and outcome of Asian patients with schizophrenia treated with risperidone over five years Gill, J.S.
 2009
 19 Supplement 2 p. S558-
1 p.
 artikel
94 P.2.d.002 The phosphodiesterase 2 inhibitor BTT5001 demonstrates anxiolytic, anti-depressive and pro-cognitive efficacy in vivo Langen, B.
 2009
 19 Supplement 2 p. S430-S431
2 p.
 artikel
95 P.2.e.008 Cardiovascular and respiratory comorbidities in patients with bipolar disorder: a systematic review Montes, J.M.
 2009
 19 Supplement 2 p. S452-S453
2 p.
 artikel
96 P.2.01 Effects of acute alcohol consumption on attentional bias: a stimuli orientation effect Adams, S.
 2009
 19 Supplement 2 p. S34-
1 p.
 artikel
97 P.4.10 Effects of early exposure to ethanol and/or a cannabinoid receptor agonist on alcohol preference at adult age in mice Molet, J.
 2009
 19 Supplement 2 p. S87-S88
2 p.
 artikel
98 P.2.e.01l Characteristics of patients with bipolar disorder presenting a current major depressive episode: analysis in 8 countries Young, A.H.
 2009
 19 Supplement 2 p. S454-S455
2 p.
 artikel
99 P.1.e.013 Lorazepam impairs processing of frequency changes andnovel sounds: combined MEG/EEG study Kahkonen, S.
 2009
 19 Supplement 2 p. S307-S308
2 p.
 artikel
100 P.3.e.01l Tobacco smoking and schizophrenia spectrum disorders in the CLAMORS study: a case-control analysis in the Spanish context Rejas, J.
 2009
 19 Supplement 2 p. S573-S574
2 p.
 artikel
101 P.2.e.019 Predictors of recurrence in bipolar I disorder: a 2-year prospective study in a Tunisian sample Mrad, A.
 2009
 19 Supplement 2 p. S459-
1 p.
 artikel
102 P.2.e.039 Prevalence and correlates of non-adherence with mood stabilisers in patients with bipolar I disorder Mechri, A.
 2009
 19 Supplement 2 p. S470-S471
2 p.
 artikel
103 P.1.e.016 Proton magnetic resonance spectroscopy study in first-episode and chronic schizophrenic patients Galinska, B.
 2009
 19 Supplement 2 p. S309-
1 p.
 artikel
104 P.1.e.030 Structural and metabolic abnormalities in bipolar I vs II disorder from combined voxel-based morphometry MRI and (18)F-fluorodeoxyglucose PET brain imaging Su, T.
 2009
 19 Supplement 2 p. S317-S318
2 p.
 artikel
105 P.6.e.010 Two years assessment in cocaine-addicted patients: linkage between alexithymia and pathological parental attachment Vigezzi, P.
 2009
 19 Supplement 2 p. S674-S675
2 p.
 artikel
106 P.2.e.025 Ziprasidone with adjunctive mood stabilizer in maintenance treatment of bipolar disorder: metabolic profiles Karayal, O.
 2009
 19 Supplement 2 p. S462-S463
2 p.
 artikel
107 P.3.f.004 Regulation of the GABA cell phenotype in neurodevelopmental model of schizophrenia in rats Basta-Kaim, A.
 2009
 19 Supplement 2 p. S583-
1 p.
 artikel
108 P.6.f.003 Rimonabant repeated treatment inhibits behavioral sensitization previously developed to morphine in mice Marinho, E.A.V.
 2009
 19 Supplement 2 p. S676-S677
2 p.
 artikel
109 P.2.g.002 Mean platelet volume in patients with major depression: effect of escitalopram treatment Canan, F.
 2009
 19 Supplement 2 p. S472-S473
2 p.
 artikel
110 P.1.g.013 Neural correlates of the impaired response inhibition in obsessive-compulsive disorder: an event-related fMRI study Kang, D.
 2009
 19 Supplement 2 p. S327-
1 p.
 artikel
111 P.1.g.009 Psychomotor performance, fatigue, sleepiness and cognitive function in in-patients with major depression Neu, D.
 2009
 19 Supplement 2 p. S325-S326
2 p.
 artikel
112 P.2.h.004 Development of a new affective temperament scale associated with the s alíele of 5-HTTLPR Gonda, X.
 2009
 19 Supplement 2 p. S480-
1 p.
 artikel
113 P.1.h.005 Incidence rate and prevalence of obsessive-compulsive disorder in treatment-seeking primary care patients Veldhuis, J.H.
 2009
 19 Supplement 2 p. S333-
1 p.
 artikel
114 P.1.i.023 Anxiety and depressive symptoms in bone marrow transplantation patients:impact on quality of life el Meguid, M. Abd
 2009
 19 Supplement 2 p. S349-
1 p.
 artikel
115 P.1.i.009 Methylphenidate for adults with attention deficit-hyperactivity disorder, a systematic review Epstein, T.
 2009
 19 Supplement 2 p. S341-
1 p.
 artikel
116 P.6.01 Incentive role of amygdaloid CRF receptors in the reinforcing effects of psychoactive drugs in rats: a new concept Shabanov, P.
 2009
 19 Supplement 2 p. S161-S162
2 p.
 artikel
117 P.1.i.043 Protective personality factors associated with premenstrual symptomatology in healthy women Gonda, X.
 2009
 19 Supplement 2 p. S358-S359
2 p.
 artikel
118 P.1.i.026 The relationships between second to fourth digit length ratio (2D:4D) and psychological characteristics Kang, D.
 2009
 19 Supplement 2 p. S350-S351
2 p.
 artikel
119 P.2.18 Lamotrigine improves anxiety-like behaviour and memory in a rat model of hypoxic-ischaemic encephalopathy Papazisis, G.
 2009
 19 Supplement 2 p. S48-S49
2 p.
 artikel
120 P.l.c.052 Paclitaxel induced pain and its character Hacimuftuoglu, A.
 2009
 19 Supplement 2 p. S281-
1 p.
 artikel
121 P.2.08 Long term follow up of adolescent depression: history of drug prescriptions Päären, A.
 2009
 19 Supplement 2 p. S148-S149
2 p.
 artikel
122 P.2.04 Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression Caggia, F.
 2009
 19 Supplement 2 p. S36-S37
2 p.
 artikel
123 P.3.05 Need-adapted treatment of first episode psychotic patients: 2-year follow-up Küünarpuu, H.
 2009
 19 Supplement 2 p. S154-
1 p.
 artikel
124 P.1.07 Prodrugs of 3-hydroxy-7-brom-5-phenyl- 1,4-benzdiazepin-2-on for oral delivery Kravchenko, I.
 2009
 19 Supplement 2 p. S135-S136
2 p.
 artikel
125 P.1.09 Psychoemotional state and cancerous growth metastases: possible roles of vasopressin Popova, N.
 2009
 19 Supplement 2 p. S137-
1 p.
 artikel
126 P.2.03 Restraint stress alters tryptophan hydroxylase 2 activity in BALB/c mice: relevance to depression Browne, C.A.
 2009
 19 Supplement 2 p. S35-S36
2 p.
 artikel
127 Proapoptotic and chemosensitizing effects of selective serotonin reuptake inhibitors on T cell lymphoma/leukemia (Jurkat) in vitro Amit, Ben Hayman
 2009
 19 Supplement 2 p. 726-734
9 p.
 artikel
128 P.1.22 Selective modulation of parvalbumin GABAergic interneuron function in-vivo in mice Murray, A.
 2009
 19 Supplement 2 p. S20-S21
2 p.
 artikel
129 P.3.17 The effects of modafinil on cognitive and emotional functions in the first episode of psychosis Scoriels, L.
 2009
 19 Supplement 2 p. S76-S77
2 p.
 artikel
130 P.8.02 The hydrolysis of 7-bromo-3-hydroxy-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one esters by pig liver microsomes Romanovskaya, I.I.
 2009
 19 Supplement 2 p. S166-S167
2 p.
 artikel
131 S.03.05 CNS infections during childhood and risk for schizophrenia: a historical-prospective study on 3,500 children hospitalised for CNS infections in childhood Weiser, M.
 2009
 19 Supplement 2 p. S180-
1 p.
 artikel
132 S.27.03 Decreased VGLUT1 levels and long-term chronic mild stress: animal models addressing specific aspects of major depression Tordera, R.M.
 2009
 19 Supplement 2 p. S214-S215
2 p.
 artikel
133 S.15.04 Defensive mobilisation and autonomic responding in anxiety disorders patients Hamm, A.
 2009
 19 Supplement 2 p. S198-
1 p.
 artikel
134 S.3.05 Developmental programming of anxiety in mice Gross, C.
 2009
 19 Supplement 2 p. S122-S123
2 p.
 artikel
135 S.22.05 Effects of stimulant treatment on subsequent substance use disorders and other psychiatric disorders in ADHD youth grown up: a prospective 10 year follow-up study Biederman, J.
 2009
 19 Supplement 2 p. S209-
1 p.
 artikel
136 S.06.02 From childhood to adulthood – testing the IMAGE candidates in IMpACT Franke, B.
 2009
 19 Supplement 2 p. S185-
1 p.
 artikel
137 S.06.05 From synthesis to uptake – serotonergic genes in adult ADHD Haavik, J.
 2009
 19 Supplement 2 p. S186-
1 p.
 artikel
138 S.3.01 Gene–environment interactions in schizophrenia Mors, O.
 2009
 19 Supplement 2 p. S119-S120
2 p.
 artikel
139 S.15.01 Heart rate dynamics during conditioned fear in mice and its implications for affective disorders Stiedl, O.
 2009
 19 Supplement 2 p. S197-
1 p.
 artikel
140 S.09.03 Long acting naltrexone implants for heroin dependence Krupitsky, E.
 2009
 19 Supplement 2 p. S192-
1 p.
 artikel
141 S.01.04 Management of the difficult-to-treat bipolar patient: a systematic approach Fountoulakis, K.
 2009
 19 Supplement 2 p. S176-
1 p.
 artikel
142 S.4.01 Molecular approaches to future treatments Koob, G.F.
 2009
 19 Supplement 2 p. S79-S80
2 p.
 artikel
143 S.19.01 Neurophysiology of histaminergic neurons in the brain Haas, H.L.
 2009
 19 Supplement 2 p. S203-
1 p.
 artikel
144 S.22.01 Translational research – from basic science of impulsivity to clinical implications Winstanley, C.A.
 2009
 19 Supplement 2 p. S208-
1 p.
 artikel
145 The antinociceptive properties of reboxetine in acute pain Schreiber, Shaul
 2009
 19 Supplement 2 p. 735-739
5 p.
 artikel
                             145 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland